Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Established in 1987, the company began research activity for microbiology solutions in 2004 and relaunched in 2012 as Accelerate Diagnostics, Inc. to develop and commercialize its first diagnostic platform. The Accelerate Pheno™ system and the Accelerate PhenoTest™ BC Kit were FDA approved in February 2017 and are clinically utilized across the globe.
